prescribing semaglutide for weight loss The FDA approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated loss, Novo Nordisk announced on Monday. The once-daily 25 Semaglutide for Weight Loss Management

Schweikert EM, Devarajan A, Witte I

According to research, probiotics seem to influence appetite and energy usage via the production of acetate, propionate, and butyrate, which are short-chain fatty acids

Not as a replacement for poor diet or a sedentary lifestyle

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), notably the long-acting agonist semaglutide, exhibit significant metabolic efficacy and pronounced neuroprotective effects across a broad spectrum of preclinical models

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes mellitus (T2DM) and weight management, have emerged as a promising treatment due to their anti-inflammatory and immunomodulatory properties